β2-microglobulin and amyloidosis

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 1, 2000, Pages 17-24

  Drueke T B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; BETA 2 MICROGLOBULIN; CALCIUM; COLLAGEN; CYTOKINE; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN LIGHT CHAIN; PROTEINASE; PROTEINASE INHIBITOR; UBIQUITIN;

AMYLOIDOSIS; ARTHRALGIA; ARTHROPATHY; CARPAL TUNNEL SYNDROME; CONFERENCE PAPER; DIALYSIS; HUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; CHRONIC KIDNEY FAILURE; METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW;

AMYLOID; AMYLOIDOSIS; ARTHRALGIA; BETA 2-MICROGLOBULIN; CARPAL TUNNEL SYNDROME; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 18744434215     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027958     Document Type: Conference Paper

References (97)

1. Bardin T, Zingraff J, Kuntz D, Drücke T. Dialysis related amyloidosis. Nephrol Dial Transplant 1986; 1: 151-154
2. Van Ypersele de Strihou C, Honhon B, Vandenbroucke JM, Huaux JP, Noël H, Maldague B. Dialysis amyloidosis. Adv Nephrol 1988; 17: 401-420
3. Jadoul M, Garbar C, Noël H, et al. Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int 1997; 51: 1928-1932
4. Zingraff J, Noël LH, Bardin T, et al. Beta-2-microglobulin amyloidosis in chronic renal failure. N Engl J Med 1990; 323: 1070-1071 (Letter)
5. Morinière P, Marie A, Esper NE, et al. Destructive spondylarthropathy with β2-microglobulin deposits in a uremic patient before chronic hemodialysis. Nephron 1991; 59: 654-657
6. Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701-706
7. Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC, Frangione B. Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest 1985; 76: 2425-2429
8. Garcia-Garcia M, Garcia-Valero J, Mourad G, Argilés A. Protein constituents of amyloid deposits in beta 2-microglobulin amyloidosis. Rev Rhum [Engl Ed] 1994; 61 (Suppl.): 7S-11S
9. Brancaccio D, Ghiggeri GM, Braidotti P, et al. Deposition of kappa and lambda light chains in amyloid filaments of dialysisrelated amyloidosis. J Am Soc Nephrol 1995; 6: 1262-1270
10. Charra B, Calemard E, Uzan M, Terrat JC, Vanel T, Laurent G. Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. Proc EDTA-ERA 1984; 21: 291-295
11. Van Ypersele de Strihou C, Jadoul M, Malghem L et al. Effect of dialysis membrane and patients' age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39: 1012-1019
12. Bardin T, Zingraff J, Shirahama T, et al. Hemodialysis associated amyloidosis and beta-2 microglobulin: a clinical and immunohistochemical study. Am J Med 1987; 83: 419-424
13. Sebert JL, Fardellone P. Deramont H, et al. Spondylarthropathie destructive avec dépòts amyloïdes chez 3 patients en hémodialyse chronique. Rev Rhum 1986; 53: 459-465
14. Sanchez R, Praga M, Salas JJR, et al. Compressive myelopathy due to dialysis-associated amyloidosis, Nephron 1993; 65: 463-465
15. Deforges-Lasseur C, Combe C, Cernier A, Vital JM, Aparicio M. Destructive spondylarthropathy presenting with progressive paraplegia in a dialysis patient. Recovery after surgical spinal cord decompression and parathyroidectomy. Nephrol Dial Transplant 1993; 8: 180-184
16. Zingraff J, Noël LH, Bardin T, Kuntz D, Dubost C, Drücke T. Beta-2 microglobulin amyloidosis: a sternoclavicular joint biopsy study in hemodialysis patients. Clin Nephrol 1990; 33: 94-97
17. Jadoul M, Malghem J, vandeBerg B, van Ypersele de Strihou C. Ultrasonographic detection of thickened joint capsules and tendons as marker of dialysis-related amyloidosis: a longitudinal and cross-sectional study. Nephrol Dial Transplant 1993; 8: 1104-1109
18. Muñoz-Gomez J, Bergada-Brado E, Gomez-Perez R, et al. Amyloid arthropathy in patients undergoing periodical hemodialysis for renal failure: a new complication. Ann Rheum Dis 1985; 44: 729-733
19. DiRaimondo C, Casey T, DiRaimondo C, Stone W. Pathologic fractures associated with idiopathic amyloidosis of bone in hemodialysis patients. Nephron 1986; 43: 22-27
20. Morita T, Suzuki M, Kaminura A, Hirasawa Y. Amyloidosis of a possible new type in patients receiving long term haemodialysis. Arch Pathol Lab Med 1985; 109: 1029-1032
21. Shirahama T, Skinner M, Cohen AS, et al. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta-2 microglobulin. Lab Invest 1985; 53: 705-709
22. Miura Y, Ishiyama T, Inomata A, et al. Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 1992; 60: 268-273
23. Grateau G, Zingraff J, Fauchet M et al. Radionuclide exploration of dialysis amyloidosis. Preliminary experience. Am J Kidney Dis 1988; 11: 231-237
24. Nelson SR, Hawkins PN, Richardson S, et al. Imaging of haemodialysis-associated amyloidosis using 123-1-serum amyloid P component. Lancet 1991; 338: 335-339
25. 131I-β2-microglobulin. Kidney Int 1990; 38: 1169-1176
26. Zingraff J, Caillat-Vigneron N, Ureña P, et al. Plasma kinetics of 125-I-labelled amyloid P component in β2-M amyloidosis: a possible approach to quantitate disease activity. Nephrol Dial Transplant 1995; 10: 223-229
27. Noël L-H, Zingraff J, Bardin T, Atienza C, Kuntz D, Drücke T. Tissue distribution of dialysis amyloidosis. Clin Nephrol 1987; 27: 175-178
28. Ogawa H, Saito A, Hirabayashi N, Hara K. Amyloid deposition in systemic organs in long-term hemodialysis patients. Clin Nephrol 1987; 28: 199-204
29. Theaker JM, Raine AEG, Rainey AJ, Heryet A, Clark A, Oliver DO. Systemic amyloidosis of β-2 microglobulin type: a complication of long term haemodialysis. J Clin Pathol 1987; 40: 1247-1251
30. Ho-Soon HC, Heller D, Picken MM, Sidhu GS, Kahn T. Infarction of intestine with massive amyloid deposition in two patients on long-term hemodialysis. Gastroenterology 1989; 96: 230-234
31. Gal R, Korzets A, Schwartz A, Rath-Wolfson L, Gafter U. Systemic distribution of β2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Arch Pathol Lab Med 1994; 118: 718-721
32. Zingraff J, Bardin T, Noël LH, Drücke T. Lack of haemodialysis associated amyloidosis. Lancet 1991; 338: 1089 (Letter)
33. Fernandez-Alonso J, Rios-Camacho C, Valenzuela-Castano A, Hernanz-Mediano W. Mixed systemic amyloidosis in a patient receiving long-term haemodialysis. J Clin Pathol 1994; 47: 560-561
34. Zingraff J, Droz D, Youam M, Voisin MC, Drücke TB. Chronic arthropathy and rectal bleeding in a long-term hemodialysis patient. Nephrol Dial Transplant 1995; 10: 2153-2155
35. Vincent C, Revillard J, Galland R, Traeger J. Serum β2-M in hemodialyzed patients. Nephron 1978; 21: 260-268
36. Hörl WH, Haag-Weber M, Georgopoulos A, Block LH. Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci USA 1990; 87: 6353-6357
37. Haag-Weber M, Mai B, Hörl WH. Isolation of a granulocyte inhibitory protein from uraemic patients with homology of β2-microglobulin. Nephrol Dial Transplant 1994; 9: 382-388
38. Gejyo F, Odani S, Yamada T, et al. β-2 microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30: 385-390
39. Floege J, Granolleras C, Bingel M et al. β-2-microglobulin kinetics during hemodialysis and hemofiltration. Nephrol Dial Transplant 1987; 1: 223-229
40. Zingraff J, Beyne P, Ureña P, et al. Influence of haemodialysis membranes on β2 microglobulin kinetics: in vivo and in vitro studies. Nephrol Dial Transplant 1988; 3: 284-290
41. Mrowka C, Schiffl H. Comparative evaluation of β2-microglobulin removal by different hemodialysis membranes: a six-year follow-up. Nephron 1993; 63: 368-369
42. Locatelli F, Mastrangelo F, Redaelli B, et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996; 50: 1293-1302
43. Odell RA, Slowiaczek P, Moran JE, Schindhelm K. Beta 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991; 39: 909-919
44. Floege J, Bartsch A, Schulze M, Shaldo NS, Koch KM, Smeby LC. Clearance and synthesis rates of β2-microglobulin in patients undergoing hemodialysis and in normal subjects. J Lab Clin Med 1991; 118: 153-165
45. Vincent C, Chanard J, Caudwell V, Lavaud S, Wong T, Revillard JP. Kinetics of 125-I-β2-microglobulin turnover in dialyzed patients. Kidney Int 1992; 42: 1434-1443
46. Messner RP. β2-Microglobulin: an old molecule assumes a new look. J Lab Clin Med 1984; 104: 141-145
47. Sonikian M, Gogusev J, Zingraff J, et al. Potential effect of metabolic acidosis on β2-microglobulin generation: in vivo and in vitro studies. J Am Soc Nephrol 1996; 7: 350-356
48. Lee S-H, Huang TS, Hsieh S-J. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients. Min Electrolyte Metab 1996; 22: 219-223
49. 2 vitamin D3 on circulating insulin-like growth factor-I and β2 microglobulin in patients with osteoporosis. Calcif Tissue Int 1997: 60: 236-239
50. Zaoui PM, Stone WJ, Hakim RM. Effects of dialysis membranes on beta 2 microglobulin production and cellular expression. Kidney Int 1990; 38: 962-968
51. 2-microglobulin synthesis by activated late complement components. Am J Kidney Dis 1993; 21: 394-399
52. Cohen AS, Connors LH. The pathogenesis and biochemistry of amyloidosis. J Pathol 1987; 151: 1-10
53. Connors L, Shirahama T, Skinner M, Fenves A, Cohen AS. In vitro formation of amyloid fibrils from intact β2-microglobulin. Biochem Biophys Res Commun 1985; 131: 1063-1068
54. Campistol JM, Solé M, Bombi JA, et al. In vitro spontaneous synthesis of β2-microglobulin amyloid fibrils. Am J Pathol 1992; 141: 241-248
55. Ono K, Uchino F. Formation of amyloid-like substance from beta-2-microglobulin in vitro. Nephron 1994; 66: 404-407
56. 2-microglobulin and advanced glycation end products in the development of dialysis related amyloidosis. Kidney Int 1997; 51: 1514-1519
57. Ohishi H, Skinner M, Sato-Araki N, Okuyama T, Gejyo F, Kimura A. Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver and spleen. Clin Chem 1990; 36: 88-91
58. Aruga E, Ozasa H, Teraoka S, Ota K. Macromolecules that are colocalized with deposits of β2-microglobulin in hemodialysis-associated amyloidosis. Lab Invest 1993; 1993: 223-230
59. Argilés A, Kerr PG, Mourad G, Mion CM, Atkins RC. Serum alpha-2-macroglobulin in haemodialysis patients: baseline and kinetic studies. Nephrol Dial Transplant 1993; 8: 1118-1123
60. 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 1989; 36: 675-681
61. Argilés A, Garcia-Garcia M, Derancourt J, Mourad G, Demaille JG. Beta 2 microglobulin isoforms in healthy individuals and in amyloid deposits. Kidney Int 1995; 48: 1397-1405
62. 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. Kidney Int 1996; 50: 1262-1267
63. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243-1252
64. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 1994; 93: 521-528
65. 2-microglobulin in renal insufficiency. Biochem J 1994; 298: 181-187
66. 2-microglobulin modified with advanced glycation end products. Kidney Int 1996; 49: 538-550
67. 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 1996; 93: 2353-2358
68. ε-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 1996; 50: 1303-1309
69. Miyasaka N, Sato K, Kitano Y, Higaki M, Nishioka K, Ohta K. Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis. Ann Rheum Dis 1992; 51: 797-802
70. Miyata T, Notoya K, Yoshida K, et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 1997; 8: 260-270
71. Friedlander MA, Wu YC, Schulak JA, Monnier VM, Hricik DE. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 1995; 25: 445-451
72. Friedlander MA, Wu YC, Elgawishi A, Monnier VM. Early and advanced glycosylation end products: kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 1996; 97: 728-735
73. Lehnert H, Jacob C, Marzoll I, Schmidt-Gayk H, Stein G, Ritz E. Prevalence of dialysis-related amyloidosis in diabetic patients. Nephrol Dial Transplant 1996; 11: 2004-2007
74. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313
75. Nguyen AT, Lethias C, Zingraff J, Herbelin A. Naret C, Descamps-Latscha B. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985; 28: 158-167
76. Capeillère-Blandin C, Delaveau T, Descamps-Latscha B. Structural modifications of human beta-2 microglobulin treated with oxygen-derived radicals. Biochem J 1991; 277: 175-182
77. Chanard J, Bindi P, Toupance O, Maheut U, Lacour F. Carpal tunnel syndrome and type of dialysis membrane. Br Med J 1989; 298: 867-868
78. Brunner FP, Brynger H, Ehrich JHH, et al. Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA Registry. Nephrol Dial Transplant 1990; 5: 432-436
79. Kessler M, Netter P, Azoulay E, Mayeux D, Pere P. Dialysis-associated arthropathy: a multicentre survey of 171 patients receiving haemodialysis for over 10 years. Br J Rheumatol 1992; 61: 157-162
80. Van Ypersele de Strihou C. Influence of dialysis techniques on β2M amyloidosis. Rev Rheum [Engl Ed] 1994; 61 (Suppl.): 67S-69S
81. Küchle C, Fricke H, Held E, Schiffl H. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol 1996; 16: 484-488
82. Cornélis F, Bardin T, Faller B, et al. Rheumatic syndromes and beta 2 microglobulin amyloidosis in patients receiving long-term peritoneal dialysis. Arthritis Rheum 1989; 32: 785-788
83. Renaud H, Fournier A, Morinière P, Westeel PF, Marie A, Sebert JL. Ostéoarthropathie multifocale associée à une amylose par dépôts de beta-2-microglobuline chez un insuffisant rénal traité uniquement par hémofiltration. Néphrologie 1988; 9: 89-94
84. Baz M, Durand C, Ragon A, et al. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artific Organs 1991; 14: 681-685
85. Tan SY, Irish A, Winearls CG et al. Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int 1996; 50: 282-289
86. Bardin T, Lebail-Darne JL, Zingraff J, et al. Dialysis arthropathy: outcome after renal transplantation. Am J Med 1995; 99: 243-248
87. Jadoul M, Noel H, Malghem J, Galant C, van Ypersele de Strihou C. Histological beta-2-microglobulin amyloidosis 10 years after a successful renal transplantation. Am J Kidney Dis 1996; 27: 888-890
88. Mourad G, Argilés A. Renal transplantation relieves the symptoms but does not reverse β2-microglobulin amyloidosis. J Am Soc Nephrol 1996; 7: 798-804
89. Jadoul M, Drüeke TB, Zingraff J, van Ypersele de Strihou C. Does dialysis-related amyloidosis regress after transplantation? Nephrol Dial Transplant 1997; 12: 655-657
90. 2-microglobulin-induced bone mineral dissolution. Kidney Int 1995; 47: 587-591
91. 2-Microglobulin induces IL-6 production from cultured neonatal mouse calvaria. J Am Soc Nephrol 1996; 7: 1472 [Abstract A1115]
92. 2-microglobulin enhances insulin-like growth factor I receptor and synthesis in bone cell cultures. J Biol Chem 1989; 264: 18268-18271
93. 2-microglobulin on in vitro calcification of osteoblastic cells. Biochem Biophys Res Commun 1986; 141: 360-366
94. Homma N, Gejyo F, Isemura M, Arakawa M. Collagen-binding affinity of beta2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 1989; 53: 37-40
95. 2-microglobulin-like proteins. Science 1989; 243: 655-657
96. 2-microglobulin, bone histology and dialysis membranes in uraemic patients. Nephrol Dial Transplant 1995; 10: 1701-1707
97. 2-microglobulin behaves as a biological marker of bone remodelling in women. Eur J Clin Invest 1996; 26: 681-685